Consumption of Apple Juice in Hemodialysis Patients

November 22, 2016 updated by: Andréia G. Giaretta, Universidade Federal de Santa Catarina

Acute Consumption of Fuji Apple Juice Does Not Affect Oxidative Stress Biomarkers in Hemodialysis Patients: A Pilot Intervention Study

The investigators hypothesized that acute consumption of Fuji apple juice (AJ) could increase the antioxidant status and/or decrease the oxidative stress (OS) biomarkers, without increasing serum biochemical parameters in patients undergoing maintenance hemodialysis (MHD). In this pre-post pilot feasibility study, patients served as their own controls, received 300 and 150 mL AJ immediately after a dialysis section, on different days, with a 3 week-washout period. Blood was collected at the baseline period, after 30 and 60 min of AJ consumption. OS biomarkers (total antioxidant status (TAS), total oxidant status (TOS), ascorbic acid, catalase (CAT), glutathione peroxidase (Gpx), superoxide dismutase (SOD) and reduced glutathione (GSH) and potassium, phosphorus, uric acid, and glucose concentrations were analyzed.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Subjects and study design

In this pre-post pilot feasibility study, subjects served as their own controls. Participants were recruited from a hemodialysis clinic, located in Florianópolis' metropolitan area, Santa Catarina state (Southern Brazil), from June to August 2015 with the following inclusion criteria: hemodialysis treatment ≥ 3 months, age ≥ 20 years, and body mass index (BMI) ≥ 23 kg/m2. Exclusion criteria were allergy to apple, presence of cancer or acquired immunodeficiency syndrome, kidney transplant less than 6 months before enrolling in the study, taking antioxidant or nutritional supplements during the 30 days before enrollment, having been hospitalized within 6 weeks before the beginning of the study, or suffering from an acute illness.

Subjects were instructed to keep their usual dietary habits for the duration of the study, except for avoiding intake of polyphenol-rich foods (i.e., vegetables, fruits and fruit-containing products, chocolate, tea, coffee, honey, and any alcoholic beverage) within 2 days before and during intervention. On two different days, each volunteer consumed 300 mL Fuji AJ, immediately after a dialysis section. After a washout period of 3 weeks, the volunteers drank 150 mL Fuji AJ in a similar manner as described above. Before and after 30 and 60 min of AJ consumption, blood samples were withdrawn for biochemical analysis. This protocol was chosen taking into account the previous favorable effects of AJ consumption on serum OS biomarkers described for healthy volunteers.

Baseline clinical and biochemical data were obtained from medical records. This study was approved by the ethics committee of human research of the Federal University of Santa Catarina (UFSC) (protocol number 37090614.6.0000.0118) and all participants gave written and informed consent.

Apple juice and analysis

Fuji apples were obtained from the Experimental Seasonal Fields at the Empresa de Pesquisa Agropecuária e Extensão Rural de Santa Catarina' Station in the city of São Joaquin, Santa Catarina, Brazil (latitude 28º 17' 39", longitude 49º 55' 56" and altitude 1.415 m), harvested in their commercial maturation stage during 2015's harvest. After harvest, apples were stored at 4 ± 1°C. To allow for a quick and easy apple intake in large amounts, 300 mL of AJ, equivalent to 3.5 apples, and 150 mL AJ, equivalent to 1.5 apples were used. Before preparing the juice, the fruits were sanitized in sodium hypochlorite. Apples with peel and no seeds were blended in a centrifugal juice extractor without water addition. Each dose of AJ was prepared and consumed immediately.

The contents of dry matter, total soluble solids, potential of hydrogen (pH) and titratable acidity of AJ were measured following official methods. The total phenolic content of the AJ extracts was measured using the Folin-Ciocalteu method colorimetric. The total flavanol content was estimated using p-dimethylaminocinnamaldehyde (DMACA) method. The total antioxidant capacity was determined using the DPPH (2,2-diphenyl-1-picryl-hydrazyl-hydrate) method. For total monomeric anthocyanin, a spectrophotometric pH differential method was used. Analyses were conducted with each AJ used in the two intervention days, in triplicate.

Blood sampling and laboratory methods

In each experiment day, blood samples from participants were collected in three different moments. Venous blood samples were collected using a vacuum system (Vacutainer Becton Dickinson BD®, São Paulo, Brazil) into heparin, Ethylenediaminetetraacetic acid (EDTA)-containing tubes or additive-free tubes. Plasma and serum were immediately obtained by centrifugation (3,000 revolutions per minute (RPM), 10 min, room temperature) for the measurement of uric acid, phosphorus, glucose, potassium, Total Antioxidant Status (TAS) and Total Oxidant Status( TOS). In order to quantify the endogenous antioxidant enzymes, an aliquot of whole blood was lysed. In order to measure reduced glutathione (GSH), an aliquot of whole blood was preserved in N-ethylmaleimide (NEM). All samples were immediately stored at -80°C for later analysis in duplicate.

Serum uric acid, phosphorus and glucose concentrations were determined using commercially available kits (Labtest Diagnóstica SA, Lagoa Santa, Minas Gerais, Brazil) in an automated multi-biochemical analyzer (Cobas Miras Plus, Roche®, Germany). Serum potassium levels were measured in an automated Dimension Max System (Siemens Healthcare Diagnostics Products®, Germany), according to the manufacturer's instructions.

TAS and TOS assays were measured spectrophotometrically, according to Erel's methods. Ascorbic acid and GSH were determined using high-performance liquid chromatography (HPLC), as previously described. The superoxide dismutase (SOD) activity was evaluated using SOD Assay Kit (Sigma Aldrich®, St. Louis, Missouri, USA) according to the manufacturer's instructions. Catalase (CAT) activity was determined spectrophotometrically according to the previously described method. The glutathione peroxidase (GPx) activity was determined using the NADPH oxidation rate method.

Study Type

Interventional

Enrollment (Actual)

6

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • hemodialysis treatment ≥ 3 months, age ≥ 20 years, and body mass index ≥ 23 kg/m2

Exclusion Criteria:

  • allergy to apple, presence of cancer or acquired immunodeficiency syndrome, kidney transplant less than 6 months before enrolling in the study, taking antioxidant or nutritional supplements during the 30 days before enrollment, having been hospitalized within 6 weeks before the beginning of the study, or suffering from an acute illness

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Apple Juice
Other: Fuji apple juice
On two different days, each volunteer consumed 300 mL Fuji apple juice (AJ), immediately after a dialysis section. After a washout period of 3 weeks, the volunteers drank 150 mL Fuji AJ in a similar manner as described above. Before and after 30 and 60 min of AJ consumption, blood samples were withdrawn for biochemical analysis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measuring oxidative stress biomarkers
Time Frame: Change from baseline at 30 and 60 minutes
Total antioxidant status (TAS) (mmol/L) and total oxidant status (TOS) (mmol/L) was measured at the baseline period, after 30 and 60 min of acute consumption of 300 and 150 mL of Fuji apple (Malus domestica Borkh) juice. Patients were not fasted for the withdrawal of blood. This measure was taken to prevent discomfort among volunteers. Venous blood samples were collected through aseptic venipuncture on the opposite arm of the arteriovenous fistula by a qualified professional using a vacuum system into heparin or EDTA-containing tubes or tubes without additives according to established standards of clinical and biological safety.
Change from baseline at 30 and 60 minutes
Measuring endogenous antioxidant enzymes
Time Frame: Change from baseline at 30 and 60 minutes
Catalase (U mg/Hb), glutathione peroxidase (U mg/Hb) and superoxide dismutase (U mg/Hb) was measured at the baseline period, after 30 and 60 min of acute consumption of 300 and 150 mL of Fuji apple (Malus domestica Borkh) juice. Patients were not fasted for the withdrawal of blood. This measure was taken to prevent discomfort among volunteers. Venous blood samples were collected through aseptic venipuncture on the opposite arm of the arteriovenous fistula by a qualified professional using a vacuum system into heparin or EDTA-containing tubes or tubes without additives according to established standards of clinical and biological safety.
Change from baseline at 30 and 60 minutes
Measuring oxidative stress biomarkers
Time Frame: Change from baseline at 30 and 60 minutes
Ascorbic acid (micromole/L) was measured at the baseline period, after 30 and 60 min of acute consumption of 300 and 150 mL of Fuji apple (Malus domestica Borkh) juice. Patients were not fasted for the withdrawal of blood. This measure was taken to prevent discomfort among volunteers. Venous blood samples were collected through aseptic venipuncture on the opposite arm of the arteriovenous fistula by a qualified professional using a vacuum system into heparin or EDTA-containing tubes or tubes without additives according to established standards of clinical and biological safety.
Change from baseline at 30 and 60 minutes
Measuring oxidative stress biomarkers
Time Frame: Change from baseline at 30 and 60 minutes
Reduced glutathione (micromole mg/Hb) was measured at the baseline period, after 30 and 60 min of acute consumption of 300 and 150 mL of Fuji apple (Malus domestica Borkh) juice. Patients were not fasted for the withdrawal of blood. This measure was taken to prevent discomfort among volunteers. Venous blood samples were collected through aseptic venipuncture on the opposite arm of the arteriovenous fistula by a qualified professional using a vacuum system into heparin or EDTA-containing tubes or tubes without additives according to established standards of clinical and biological safety.
Change from baseline at 30 and 60 minutes
Measuring serum biochemical parameters
Time Frame: Change from baseline at 30 and 60 minutes
Potassium (mmol/L), phosphorus (mmol/L) and glucose (mmol/L) was measured at the baseline period, after 30 and 60 min of acute consumption of 300 and 150 mL of Fuji apple (Malus domestica Borkh) juice. Patients were not fasted for the withdrawal of blood. This measure was taken to prevent discomfort among volunteers. Venous blood samples were collected through aseptic venipuncture on the opposite arm of the arteriovenous fistula by a qualified professional using a vacuum system into heparin or EDTA-containing tubes or tubes without additives according to established standards of clinical and biological safety.
Change from baseline at 30 and 60 minutes
Measuring serum biochemical parameters
Time Frame: Change from baseline at 30 and 60 minutes
Uric acid (micromole/L) was measured at the baseline period, after 30 and 60 min of acute consumption of 300 and 150 mL of Fuji apple (Malus domestica Borkh) juice. Patients were not fasted for the withdrawal of blood. This measure was taken to prevent discomfort among volunteers. Venous blood samples were collected through aseptic venipuncture on the opposite arm of the arteriovenous fistula by a qualified professional using a vacuum system into heparin or EDTA-containing tubes or tubes without additives according to established standards of clinical and biological safety.
Change from baseline at 30 and 60 minutes
Evaluating heigth
Time Frame: at baseline
Height (meters) data were obtained from the patient's files.
at baseline
Evaluating weight
Time Frame: At baseline
Weight (kilograms) data were obtained from the patient's files.
At baseline
Evaluating body mass index
Time Frame: At baseline
Body mass index (BMI) (Kg/m2) data were obtained from the patient's files.
At baseline
Evaluating medication
Time Frame: At baseline
Medication data were obtained from the patient's files.
At baseline
Evaluating adequacy of the dialysis treatment
Time Frame: At baseline
Adequacy of the dialysis treatment was captured by extracting the routine Kt/V from the medical record.
At baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universidade Federal de Santa Catarina

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2015

Primary Completion (Actual)

October 1, 2015

Study Completion (Actual)

October 1, 2015

Study Registration Dates

First Submitted

November 10, 2016

First Submitted That Met QC Criteria

November 22, 2016

First Posted (Estimate)

November 28, 2016

Study Record Updates

Last Update Posted (Estimate)

November 28, 2016

Last Update Submitted That Met QC Criteria

November 22, 2016

Last Verified

November 1, 2016

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 37090614.6.0000.0118

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Oxidative Stress

Clinical Trials on Fuji apple juice

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe